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Abstract
Mercury (Hg) is a potent neurotoxicant. We hypothesized that single nucleotide polymorphisms
(SNPs) in genes coding glutathione-related proteins, selenoproteins and metallothioneins may
modify the relationship of mercury biomarkers with changes in peripheral nerve function. Dental
professionals (n=515) were recruited in 2009 and 2010. Sensory nerve function (onset latency,
peak latency and amplitude) of the median, ulnar and sural nerves were recorded. Samples of
urine, hair and DNA were collected. Covariates related to demographics, nerve function and
elemental and methyl- mercury exposure were also collected. Subjects included 244 dentists
(47.4%) and 269 non-dentists (52.2%; mostly dental hygienists and dental assistants). The mean
mercury levels in urine (1.06μg/L) and hair (0.51μg/g) were not significantly different from the
US general population (0.95 μg/L and 0.47μg/g, respectively). In multivariate linear models
predicting nerve function adjusting for covariates, only 3 out of a total of 504 models showed
stable and statistically significant interaction of SNPs with mercury biomarkers. Overall, given the
possibility of false positives, the results suggested little evidence of effect modification of the
SNPs on the relationship between mercury biomarkers with peripheral nerve function at exposure
levels that are relevant to the general US population.
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1. Introduction
Mercury is ubiquitous in the environment. The general population has low but measurable
levels of mercury in hair (mostly through fish consumption) and urine (mostly through
dental amalgam). Much of the work on the peripheral neurological impact of mercury has
been based on clinical neurological examinations of the peripheral nervous system at high
levels of exposure (Albers et al. 1982; Albers et al. 1988; Ellingsen et al. 1993; Letz et al.
2000; Levine et al. 1982). However, clinical neurological examinations may not be adequate
to detect subclinical effects of low-level exposure to methylmercury and elemental mercury.
Nerve conduction tests, widely used in clinical practice and research to evaluate peripheral
neuropathy, can serve as an objective measure of peripheral nerve impairment in relation to
mercury at low levels.
There are four prior studies of low-level elemental mercury exposure in which clinical
neurological examinations were used to associate signs and symptoms of peripheral
neuropathy with elemental mercury exposures (DeRouen et al. 2006; Echeverria et al. 2005;
Echeverria et al. 2006; Kingman et al. 2005). Two of these studies employed nerve
conduction tests, but they focused solely on motor nerve conduction (DeRouen et al. 2006;
Echeverria et al. 2005). Motor nerve conduction is generally considered a less sensitive
indicator of peripheral nerve impairment than sensory nerve conduction (Shefner and
Dawson. 1990). Furthermore, ulnar nerve conduction in the hand was the only measurement
used in the two studies. However, the use of the sural nerve in the lower extremities is likely
to be more sensitive to the effects of peripheral neurotoxicants than the ulnar or median
nerves in the hand as nerves with longer axons are typically more susceptible to
neurotoxicants. This has been shown in patients with most forms of neurotoxin- or
neurotoxicant-induced peripheral neuropathy (Kimura, 1983). Although three of the four
studies reported vibration sensitivity of toes and fingers in relation to elemental mercury
exposure (Echeverria et al. 2005; Echeverria et al. 2006; Kingman et al. 2005), sensory
nerve conduction is considered a more objective index of peripheral nerve impairment
compared to vibrotactile measurement in the lower extremities (Kingman et al. 2005). A
study that employs nerve conduction of sensory nerves (including the sural nerve) in the
investigation of the association of peripheral nerve function with elemental mercury
exposure is warranted. There has been no prior study of low-level methylmercury exposure
in relation to the peripheral nervous system.
Combined with five other prior studies (Custodio et al. 2004; Custodio et al. 2005;
Gundacker et al. 2007; Gundacker et al. 2009; Schläwicke Engström et al. 2008), our recent
findings suggested that single nucleotide polymorphisms (SNPs) in metallothionein (MT)
genes, key glutathione synthesizing genes (glutamate cysteine ligase (GCL)), glutathione-S-
transferase genes (GST) and selenoprotein genes may modify the relationship of low-level
exposure to elemental mercury and methylmercury with biomarker levels in urine and hair
(Goodrich et al. 2011; Wang et al. 2011). While the underlying mechanism for such effect
modification was not clear, these polymorphisms were hypothesized to influence mercury-
binding capacity of the enzymes and the protein products through alternations of gene
expression and enzyme activity. Furthermore, protein products of these genes all have been
found to serve as anti-oxidants in humans (Aschner et al. 2006; Kumari M.V. et al. 1998;
Ravn-Haren et al. 2006; Schurz et al. 2000). Anti-oxidants have been found to improve
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nerve function through reduction of oxidative stress in rodents (Cameron et al. 1993;
Vincent et al. 2007).
In light of all these findings and the potential subclinical impact of mercury on peripheral
nerve function, we extended our investigation of effect modification of these SNPs into the
relationship between nerve function and mercury levels in urine and hair. In particular, the
two previous studies that did use nerve function did not find any association between
biomarkers and nerve function, and they might have missed subtle effects of mercury due to
(unmeasured) interactions between genetic polymorphisms and mercury biomarkers. By
employing sensory nerve function and assessment of SNPs of key metallothionein,
selenoprotein and glutathione-related proteins, the goal of the present study was to evaluate
potential interaction between SNPs and mercury biomarker levels (both urine and hair) on
nerve function at an exposure level that is relevant to the US general population.
2. Materials and Methods
Subjects were recruited during the Michigan Dental Association (MDA) annual conventions
held in 2009 (n=232) and 2010 (n=283). They represent a convenience sample of dental
professionals who attended the conventions. Participants provided written consent. The
study was approved by the University of Michigan Institutional Review Board. Subjects
completed a self-administered questionnaire to provide information about recent mercury
exposures from sources of both elemental mercury and methylmercury, demographic
information, history of pre-existing diseases and other covariates.
2.1 Urine and Hair Specimens
Each subject provided a spot urine sample in a mercury-free container (Becton, Dickinson,
and Company; NJ, USA). A minimum of 10 mg (approximately 10–20 hair strands) of hair
was collected from the occipital region of the head. We were not able to obtain urine and
hair samples from 13 and 10 subjects, respectively.
Total mercury content in urine and hair (first 2cm hair closest to the scalp) samples was
determined using atomic absorption spectroscopy in the Direct Mercury Analyzer-80
(DMA-80, Milestone Inc., Shelton, CT) based on US Environmental Protection Agency
Method 7473 as described elsewhere (Goodrich et al. 2011). No hair or urine sample was
below the Theoretical Method Detection Limit (TMDL), calculated as 3 times the standard
deviation of measurement averages of all blanks (urine-2009:0.05ng; 2010: 0.01ng;
hair-2009: 0.07ng; 2010: 0.01ng).
2.2 Measurements of Nerve Conduction Function
Nerve conduction function measures the electrical conductivity of a nerve in response to
stimulus. Sensory nerve conduction was performed on each subject and included
measurements of amplitude, onset latency and peak latency of the median and ulnar sensory
nerves in the right wrist and the sural nerve in the right ankle. In general, higher amplitude
and lower latency reflect better nerve function. The temperatures of the right midpalm and
midfoot at the time of measurements were also recorded. The hand and/or foot was warmed
with electric heating pads if the limb was initially below 32 °C.
Antidromic stimulation was applied 14cm proximal to standard ring-shaped recording
electrodes, separated by a distance of 3cm and placed on digits II and V of the right upper
extremity for median and ulnar sensory nerves, respectively. A TECA Synergy (Oxford
Instrument, Hawthorne, NY) was used to record the amplitude, onset latency and peak
latency upon the stimulation over the median and ulnar sensory nerves. For measuring nerve
conduction of the sural sensory nerve, antidromic stimulation was applied on the posterior
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aspect of the right calf, 14cm proximal to the recording electrode placed behind the lateral
malleolus in the lower extremity. The peak and onset latencies (milliseconds-ms) were
defined as the time required for an electrical stimulus to initiate the first peak of an action
potential waveform and the time to deflect from baseline of waveform, respectively. The
amplitude (microvolts-μV) was defined as the baseline-to-peak voltage difference on a
waveform. All parameters were recorded in accordance with the guidelines outlined by the
American Association of Electrodiagnostic Medicine (American Association of
Electrodiagnostic Medicine. 2002).
2.3 Hand Diagrams
A standard self-administrated hand diagram was given to each participate (Katz and Stirrat.
1990; Katz et al. 1990). Subjects shaded the areas where numbness, tingling, burning or pain
had occurred more than three times, or had lasted more than one week in the six months
prior to the measurement. The diagrams were then reviewed and scored independently by
two experienced physicians for symptoms consistent with Carpel Tunnel Syndrome (CTS).
Discrepancies in the results were reconciled through consensus.
2.4 SNP Selection and Genotyping
Buccal swabs were used to collect DNA samples (Goodrich et al. 2011). Genomic DNA was
isolated and purified for genotyping using Promega SV Genomic kits (Promega
Corporation, Fitchburg, WI). A total of twenty-six SNPs and two deletion polymorphisms in
genes important for mercury metabolism such as metallothionein, selenoprotein and
glutathione-related proteins were genotyped using TaqMan Allelic Discrimination Assay
(Applied Biosystems, Foster City, CA), Restriction Fragmentation Length Polymorphism
(RFLP) genotyping or PCR-based deletion-detecting method (See Appendix A Table A.1).
We selected fifteen SNPs from selenoprotein and glutathione-related genes along with
thirteen metallothionein SNPs (See Appendix A Table A.1). Ten of these polymorphisms
(GSTP1-105, GSTP1-114, GSTT1 deletion, GSTM1 deletion, GCLM -588, GCLC -129,
MT1M (rs2270836), MT1A (rs8052394), MT1E (rs708274), and MT1M (rs9936741)) have
been previously reported to significantly modify the mercury biomarker-exposure
relationship in humans (Custodio et al. 2004; Custodio et al. 2005; Gundacker et al. 2007;
Gundacker et al. 2009; Schläwicke Engström et al. 2008). The eighteen remaining SNPs
were chosen based on: 1) the importance of the gene category to which they belong in
mercury metabolism (glutathione s-transferases, enzymes involved in glutathione synthesis,
selenoproteins or metallothionein); 2) SNP minor allele frequency ≥ 5% in the Centre
d’Etude du Polymorphisme Humain (CEPH) panel as reported in the PubMed SNP
database; 3) a known or hypothesized effect of SNP on enzyme function or gene expression
(e.g., the SNP encodes an amino acid change or a change in an important regulatory region
such as the 5′UTR or 3′UTR). All selected SNPs had minor allele frequencies ≥ 5% and all
met Hardy-Weinberg Equilibrium (HWE). Not all SNPs were genotyped in subjects from
both sampling years (See Appendix A Table A.1)
2.5 Statistical Methods
2.5.1 Exclusion Criteria—Different exclusion criteria were applied to models depending
on the specific analyses involved. We excluded subjects with self-reported conditions that
have an impact on nerve function or kidney function. One subject with Charcot-Marie-Tooth
(CMT) and three pregnant women were excluded from all analyses. When urinary mercury
was included in the analyses, we excluded 8 subjects with preexisting kidney diseases
(lithiasis, pyelonephritis, orthostatic proteinuria, end stage kidney disease or chronic renal
failure). For modeling nerve conduction of ulnar and sural sensory nerves in relation to
urinary mercury, we additionally excluded 24 subjects with self-reported history of stroke or
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diabetes. For modeling nerve conduction of the median sensory nerve in relation to urinary
mercury, we additionally excluded 48 subjects with a self-reported history of CTS or
rheumatoid arthritis along with 11 additional subjects diagnosed with CTS from the hand
diagram. For analyses of ulnar or median sensory nerves in relation to hair mercury, only
subjects with stroke or diabetes were excluded. For the median nerve in relation to hair
mercury level, the 48 additional subjects with a history of CTS or rheumatoid arthritis along
with the 11 additional subjects diagnosed with CTS from the hand diagram were excluded.
As a result, the final sample sizes were of 405, 474 and 465 for median, ulnar and sural
nerves, respectively after excluding missing urine and hair measurements.
2.5.2 Statistical Methods—All statistical analyses were performed in SAS 9.2 (SAS
Institute Inc., Cary, NC). The multivariate linear regression analyses were conducted in
three phases. In the first phase, using multivariate linear regression models, each log-
transformed nerve conduction measurement was regressed against covariates including race,
gender, height, weight, age, occupation, dominant hand, hand temperature and foot
temperature. A base model predicting each nerve measurement was then formed using the
statistically significant predictors derived from the first phase of analyses. A total of nine
base models were developed for amplitude, onset latency and peak latency of the median,
ulnar and sural nerves (See Appendix B Table B.1). In the second phase, urine and hair
mercury biomarker levels were independently added to each of the nine base models
resulting in eighteen models (See Appendix B Table B.1). In the third phase of the analyses,
for each SNP, the main effects and interaction terms with the mercury biomarker using
dummy variables for the heterozygote and minor homozygote with the major homozygote as
referent were added to the eighteen models (Appendix B Table B.2). Such interactions were
investigated one SNP at a time in separate models, resulting in a total of 504 (18 × 28)
separate models. The SNP-biomarker interaction was the main outcome of interest. For each
of the models (12 out of 504) that achieved statistical significance in SNP-biomarker
interaction terms, a sensitivity analysis was performed to identify influential observations
whose urine or hair mercury levels had “large” impact on respective nerve function
modeled. In each of the 12 models, a subject was considered a potentially influential
observation if the absolute value of the DFBETA statistic of a biomarker-dependent variable
(either urine or hair mercury biomarker) in relation to the respective modeled nerve
conduction measurement was equal to/greater than the conventional cutoff value (2/
sqrt(regression model sample size)). These influential observations were ranked in
descending order according to the DFBETA statistics and were excluded if the Cook’s D
statistic of the observations exceeded the conventional cutoff value (4/(regression model
sample size)) in the sensitivity analysis. Models were labeled as “stable” if exclusion of any
or all influential observations did not affect the significance or parameter estimate direction
of interaction terms. Models were labeled “unstable” if such exclusion resulted in changes of
parameter significance (from significant to nonsignificant) or in the direction of interaction
parameter estimates (See Appendix Table B.2). The default significance level was 0.05.
3. Results
3.1 Demographics
The total sample includes 515 subjects (Table 1) and is predominantly Caucasian (90.5%).
Dentists comprised 47.4% of the sample. There were 198 males (38.5%). Thirty six percent
(n=184) of the subjects were male dentists while about 50% (n=255) were female non-
dentists. The mean ages for dentists and non-dentists were 56.1 and 48.2 years old,
respectively, and this difference was significant. The mean ages for Caucasians and non-
Caucasians are 52.5 and 46.8 years old, respectively, and they also differed significantly.
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The mean Body Mass Indices (BMIs) of dentists and non-dentists did not differ significantly
and neither did that of Caucasians and non-Caucasians.
3.2 Levels of Urine and Hair Biomarkers
Both the geometric mean levels of urinary and hair mercury in our study are higher than that
in the US general population but the distributions did not differ significantly from the US
general population (see Appendix Tables A.2).
3.3 Associations between Nerve Conduction Measurements and Covariates
Table 2 shows the overall mean results of nerve conduction measurements (amplitude, onset
latency and peak latency) for all three nerves tested (median, ulnar and sural). The log-
transformed nerve conduction measurements of all three nerves were predicted by different
sets of covariates in multivariate linear regression models (see Appendix Table B.1).
Increased age was shown to be inversely associated with measured nerve function across all
nerve conduction measurements. “Better” nerve function was observed in females compared
to males for all ulnar models in which gender was a significant covariate. BMI was inversely
associated with nerve function in all median models. Height was inversely associated with
nerve function in all sural models. Limb temperature was inversely associated with latency
in all nerves and ulnar nerve amplitude but was not significantly associated with amplitude
in the median or sural nerves.
3.4 Results of Stable Multivariate Regression Models Exploring Effect Modification of
Selected SNPs (Adjusted for mercury levels in Urine and Hair and Covariates)
Only 3 out of 504 multivariate linear regression models of log-transformed nerve conduction
measurements achieved stable, statistical significance for the SNP-biomarker interaction
terms (Table 3). Compared to those with CC genotypes, subjects with CT genotypes of the
GPX1 (rs1050450) SNP had lower ulnar peak latency for the same increment of urine
mercury levels. Subjects with GA genotypes of the GCLC 5′UTR (rs17883901) SNP had
higher sural amplitude compared to those with GG genotypes for the same increment of hair
mercury levels. Subjects with GT or TT genotypes of the MT1E 3′UTR (rs708274) had
higher ulnar onset latency compared to those with GG genotypes for the same increment of
hair mercury levels. A stratification analysis of respective nerve measurements for these
three genotypes showed no statistically significant differences between genotypes (Table 4).
3.5 Results of Unstable Multivariate Regression Models Exploring Effect Modification of
Selected SNPs (Adjusted for mercury levels in Urine and Hair and Covariates)
Nine other multivariate linear regression models (out of 504 models) of log-transformed
nerve conduction measurements also achieved statistical significance for the SNP-biomarker
interaction terms (See Appendix Table B.2). However, these results were unstable and did
not hold up after excluding potentially influential observations.
4. Discussion
We measured sensory nerve conduction function including amplitude, onset latency and
peak latency in median, ulnar and sural nerves, respectively in a dental population exposed
to elemental and methyl- mercury at levels similar to the US general population. We
explored whether SNPs and deletion polymorphisms in genes related to mercury metabolism
may modify the association of mercury levels in urine and hair, respectively with nerve
conduction measurements in multivariate linear regression models. Only 3 out of 504
multivariate models that investigated effect modification of SNPs achieved stable
significance in those interaction terms (Table 3). In another 9 models, unstable significant
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interaction terms were found and such effect modification did not hold after sensitivity
analyses were performed on those models (See Appendix Table B.2). Given the few stable
significant findings, the results provide little evidence of effect modification of the SNPs on
the relationship between mercury biomarker levels and peripheral nerve function.
The median and ulnar nerve conduction values in our study were within the range of values
previously reported in workers but with a mean age 16 years younger than the present study
(Salerno D F et al. 1998). The sural nerve values were also within the expected range
(Schuchmann. 1977). Coefficients of covariates in models predicting nerve function, such as
age, gender, height, weight, BMI, and temperature, were similar in magnitude and direction
to those reported in prior studies (Fujimaki et al. 2009; Greathouse et al. 1989; Kimura,
1984; Letz and Gerr. 1994; Rivner et al. 2001; Robinson et al. 1993; Salerno D F et al. 1998;
Tong et al. 2004; Trojaborg et al. 1992; Werner and Franzblau. 1996; Werner. 2006).
We are not aware of any prior study that has looked at the effect of genetic polymorphisms
on the associations between nerve function and mercury levels in urine or hair. Given the
small number of stable and significant interaction terms (n=3) and the large number of
models tested (n=504), it is not possible to rule out that the effect modification of GPX1
(rs1050450), GCLC 5′UTR (rs17883901) and MT1E 3′UTR (rs708274) SNPs may be false
positives as a result of multiple comparisons. Therefore, we conclude that there is no
sufficient evidence of effect modification of these SNPs on the relationship between nerve
function and mercury burden in the body. However, given the significant findings from our
prior studies which indicated that some of these SNPs modify the relationship between
mercury exposure and biomarker levels (Goodrich et al. 2011; Wang et al. 2011), our
present null result suggests that the effect modification of these SNPs in explaining the
variability of health effects in response to mercury exposure is restricted to the exposure-
biomarker relationship. Thus, any observed variation of nerve function in response to
mercury may be explained primarily through enzyme binding of mercury at a metabolic
level, as hypothesized in our prior studies (Goodrich et al. 2011; Wang et al. 2011)..
Differential findings of the effects of the SNPs on outcome-biomarker (urine or hair)
relationship are not surprising given that the binding of heavy metals depend on several
factors: abundance of the enzymes/proteins in target tissues, mercury form in target tissues
and redox chemistry of the enzymes/proteins. Inorganic mercury and methylmercury differ
in their target organs (kidney versus brain) and elimination routes (urine versus feces). Thus,
levels of enzymes/proteins vary across the target tissues, which may contribute to the
differential modifications.
The study suffers from a number of limitations. First, the study has a relatively small sample
size of dental professionals available for analysis. For some SNPs, e.g. MT1M (rs2270836),
there were fewer than 15 subjects with the homozygous variant genotype. The small
numbers limit the power of our study to assess effect modification of mercury metabolism
related genes on outcome-biomarker relationships. Second, our study group was a
convenience sample, not a random sample. However, there is no reason to believe that
subjects had any prior knowledge of their genotypes or mercury levels. Nevertheless,
convenience samples may have other hidden biases. For example, our subjects were
predominately Caucasian, which may have introduced bias. Third, the selection of SNPs was
based on their potential relationships with mercury exposures rather than adverse
neurological outcomes. Without taking into account SNPs related to adverse neurological
diseases, it may not be surprising to have found so few stable and significant results out of
the 504 models examined. Despite the fact that nerve conduction is a sensitive and objective
technique for assessing peripheral nerve impairment, variability and errors in those
measurements may still contribute to the inconsistent results for sural nerve measurements
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(Kimura, 1984). In our study, the sural nerve did not appear to be more susceptible to
mercury compared to the ulnar or median nerves (See Appendix Table B.1). Due to the
length of the sural nerve, greater variability may exist in the sural measurements compared
to those for median and ulnar nerves. The results are relevant to the general population
although they might not be generalizable to non-Caucasian population.
We did not correct for potential multiple comparison errors due to potential high correlations
between nerve measurements (r>0.85 within the same nerve; r<0.5 within the same type of
measure between nerves) in different nerves when analyzing modifying effects of SNPs on
the relationship of nerve function with mercury levels in hair and urine. Since there were so
few significant interaction terms showing modifying effects, we would not have drawn a
conclusion that was any different from the current one had we made such correction. Any
correction for multiple comparisons would have decreased the default cutoff p value
(p=0.05) and thus resulted in even fewer or no significant results since most of the p value
ranged from 0.01 to 0.05.
5. Conclusion
The study is the first to investigate the potential modifying effects of key SNPs related to
mercury metabolism on the relationships between low-level mercury in both urine and hair,
respectively with objective sensory nerve function measurements in median, ulnar and sural
nerves. We carried out the study in a predominately white population with mercury
biomarker levels relevant to the US general population. Overall, given the possibility of
false positives the results suggest little evidence of effect modification of the SNPs on the
relationship between mercury biomarkers and peripheral nerve function. Future research is
needed to fully investigate the role of genetic polymorphisms in the development of adverse
neurological outcomes related to mercury exposures.
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1. First to investigate modifying effects of SNPs on biomarker-nerve associations
2. Results are applicable to the US general population
3. No modifying effects of glutathione protein, selenoprotein and metallothionein
SNPs
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Table 1
Demographics
N Age (year;SD) BMI (kg/m2;SD) Female
Occupation
 Dentist 244 56.1 (11.6)* 26.4 (4.0) 60 (24.6%)
 Non-dentist 269 48.2 (11.2)* 26.4 (5.3) 255(94.8%)
 Subtotal 513 315 (61.4%)
 Missing 2 2
Race
 Caucasian 463 52.5 (11.9)# 26.3 (4.6)








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Sci Total Environ. Author manuscript; available in PMC 2013 February 15.
